Rosetta Capital

Rosetta Capital operates as a specialized venture capital firm concentrating on the life sciences and medical device sectors. The firm primarily executes direct secondary transactions, offering tailored liquidity solutions to investors and corporations within its portfolio. This approach allows them to address specific capital needs while facilitating growth across their diverse range of investments.

Established in 2001, Rosetta Capital was founded to identify and nurture nascent innovations within the healthcare landscape. The firm leverages its team’s deep expertise in management, investment, and scientific fields to support the development of breakthrough technologies. Its foundation is rooted in a commitment to fostering companies that significantly impact patient well-being.

Rosetta Capital partners with innovative life sciences and medical device companies, empowering entrepreneurs to advance their therapeutic and diagnostic solutions. The firm's long-term vision centers on building world-class healthcare companies, driving progress that ultimately transforms patient lives. It aims to be a steadfast partner for companies dedicated to solving critical health challenges.